Alveolar macrophages (AMs) can phagocytose unopsonized pathogens such as S. aureus via innate immune receptors, such as scavenger receptors (SRs). Cytoskeletal events and signaling pathways involved in phagocytosis of unopsonized bacteria likely govern the fate of ingested pathogens, but are poorly characterized. We have developed a high-throughput scanning cytometry-based assay to quantify phagocytosis of S. aureus by adherent human blood-derived AM-like macrophages in a 96-well microplate format. Differential fluorescent labeling of internalized vs. bound bacteria or beads allowed automated image analysis of collapsed confocal stack images acquired by scanning cytometry, and quantification of total particles bound and percent of particles internalized. We compared the effects of the classic SR blocker polyinosinic acid, the cytoskeletal inhibitors cytochalasin D and nocodazole, and the signaling inhibitors staurosporine, Gö 6976, JNK Inhibitor I and KN-93, on phagocytosis of a panel of live unopsonized S. aureus strains, (Wood, Seattle 1945 (ATCC 25923), and RN6390), as well as a commercial killed Wood strain, heat-killed Wood strain and latex beads. Our results revealed failure of the SR inhibitor polyinosinic acid to block binding of any live S. aureus strains, suggesting that SR-mediated uptake of a commercial killed fluorescent bacterial particle does not accurately model interaction with viable bacteria. We also observed heterogeneity in the effects of cytoskeletal and signaling inhibitors on internalization of different S. aureus strains. The data suggest that uptake of unopsonized live S. aureus by human macrophages is not mediated by SRs, and that the cellular mechanical and signaling processes that mediate S. aureus phagocytosis vary. The findings also demonstrate the potential utility of high-throughput scanning cytometry techniques to study phagocytosis of S. aureus and other organisms in greater detail.
Citation: DeLoid GM, Sulahian TH, Imrich A, Kobzik L (2009) Heterogeneity in Macrophage Phagocytosis of Staphylococcus aureus Strains: High-Throughput Scanning Cytometry-Based Analysis. PLoS ONE 4(7): e6209. https://doi.org/10.1371/journal.pone.0006209
Editor: Stefan Bereswill, Charité-Universitätsmedizin Berlin, Germany
Received: April 2, 2009; Accepted: June 10, 2009; Published: July 10, 2009
Copyright: © 2009 DeLoid et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by NIH R01 grants (R01 ESO11008 and R01 ESO11903) and T32 grant (T32-HL007118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Staphylococcus aureus is an increasingly frequent and dangerous cause of both community and hospital-acquired pneumonia . The alveolar macrophage (AM) is the primary resident defender against inhaled pathogens such as S. aureus that reach the alveoli. In the absence of specific opsonizing antibodies, the AMs ability to clear these pathogens depends upon its innate immune receptors for binding and internalization. In particular, the group of molecular pattern recognition receptors (PRR) collectively known as scavenger receptors (SRs) function in the uptake of unopsonized bacterial pathogens –. SRs are a diverse group of receptors with broad and overlapping specificities that mediate binding and internalization of many polyanionic ligands, including bacteria and their cell wall components, oxidized low density lipoproteins, environmental dusts, apoptotic cells, and CpG DNA. To date, eight classes of SA (A-H) have been described (reviewed in ). The most extensively studied in terms of their potential roles in host defense against S. aureus are the class A scavenger receptors SR-AI/II, and macrophage receptor with collagenous structure (MARCO). SR-A I/II binds both Gram-positive and Gram-negative bacteria and their respective cell wall products lipoteichoic acid and lipopolysaccaride , , . Investigators have used a convenient fluorescence-labeled S. aureus to observe its SR-AI/II-mediated phagocytosis by SR-A transfected CHO cells as well as by human bone-marrow derived macrophages . Moreover, SR-A deficient mice have diminished clearance of S. aureus and survival following IP infection, and macrophages from SR-A deficient mice exhibit diminished phagocytosis of S. aureus . Another class A SR, MARCO, also binds E. coli and S. aureus, and this binding is blocked by anti-MARCO antibody, as well as by the general SR binding inhibitors polyinosinic acid and polyguanylic acid , , . Other SRs that have been implicated as potential mediators of unopsonized pathogen phagocytosis by macrophages include the class A scavenger receptor with C-type lectin (SRCL), also known as collectin placenta-1 (CL-P1) –, the class E lectin-like oxidized low-density lipoprotein receptor (LOX-1) –, and the class G scavenger receptor that binds phosphatidylserine and oxidized lipoprotein (SR-PSOX), also known as CXC chemokine ligand 16 (CXCL16) , .
The binding of pathogen ligands or opsonins by macrophage surface receptors initiates signaling cascades. These, in turn, that activate the cytoskeletal machinery responsible for endocytosis and (possibly) for cell activation responses. The signaling events and cytoskeletal elements and activities involved in FcγR-mediated and CR-mediated phagocytosis have been fairly well characterized –. We have previously used a scanning cytometry assay to analyze macrophage phagocytosis of unopsonized latex beads. This study revealed that several cytoskeletal and signaling components previously implicated in FcγR-mediated phagocytosis (tyrosine kinases, protein kinase C (PKC), in complement-mediated phagocytosis (microtubules), or in both (actin, phosphoinositide 3-kinase (PI3K)), as well the MAPK family members JNK and MEK/ERK, are important factors in macrophage uptake of unopsonized albumin-coated latex beads .
To allow similar analysis of unopsonized phagocytosis of specific bacterial pathogens we have developed high-throughput fluorescent scanning cytometry-based methods for quantification of phagocytosis of S. aureus by adherent human alveolar-like macrophages in a 96-well microplate format. Methods for differential fluorescent labeling of internalized vs. external bacteria were devised to enable automated image analysis of collapsed confocal stack images from scanning cytometry. Analysis and quantification software was developed to provide enumeration of internalized, bound external and total bacteria per cell, and calculation of mean bacteria per cell and fraction of bacteria internalized within each microplate well. The format made it possible to test a panel of inhibitors of pathways related to phagocytosis. The data confirmed the role of scavenger receptors in binding of the popular commercially available fluorescent S. aureus-derived particles. In contrast, macrophages showed SR-independent uptake of a panel of other S. aureus strains (live and heat-killed). Strain-specific heterogeneity in the effects of signaling inhibitors was also seen.
Materials and Methods
Human cell isolation and preparation
Human peripheral blood monocyte-derived, granulocyte and macrophage-colony stimulating factor (GM-CSF)-matured MФs (GM-MФs) were prepared as previously described . Briefly, buffy coats harvested from blood obtained from discarded platelet apheresis collars obtained from the Kraft Family Blood Donor Center at the Dana Farber Cancer Institute (Boston, MA, USA) were enriched for monocytes using the RosetteSep Monocyte Enrichment kit (Stem Cell Technologies, Vancouver, BC, Canada). Monocytes were cultured in Vuelife bags (American Fluoroseal, Gaithersburg, MD, USA) at 5% CO2 and 37°C in RPMI/10% FBS with 20 µg/ml gentamycin and 20 ng/ml human recombinant GM-CSF (Peprotech, Rocky Hill, NJ, USA). For adherent cell studies harvested cells were resuspended at 5×105/ml in RPMI/10% FBS and dispensed into black-walled 96 well Micro-Clear plates (Greiner Bio-One, Monroe, NC, USA) at 1×105 cells/well, and incubated for 48 hours at 5% CO2 and 37°C. For suspension cell flow cytometry studies harvested cells were resuspended at 5×105/ml in RPMI/ 0.3% BSA and stored on ice until time of assay (less than one hour).
Mouse cell isolation and preparation
Animal experiments and husbandry were approved by the Harvard Medical Area Standing Committee on Animals. 4–6 week-old female BALB/c mice (Jackson Laboratory, Bar Harbor, ME, USA) were injected i.p. with 2 ml aged thioglycolate broth (Sigma-Aldrich, St. Louis, MO, USA). Four days post injection mice were anesthetized with isofluorane and euthanized by cervical dislocation. Peritoneal lavage was performed with 10 ml. ice-cold PBS and pooled samples from three mice were centrifuged at 500× g for 8 minutes. Cells were resuspended at 5×105/ml in RPMI/10% FBS and dispensed into black-walled 96 well Micro-Clear plates (Greiner Bio-One, Monroe, NC, USA) at 1×105 cells/well, and incubated for 48 hours at 5% CO2 and 37°C.
Preparation of live S. aureus suspensions
S. aureus strains Seattle 1945 (ATCC 25923), Wood, and ATCC 12598 (Cowan 1) were purchased from American Type Culture Collections (ATCC, Manassas, VA, USA). Green fluorescent protein (GFP)-expressing S. aureus strain RN6390 was generously donated by Dr. Ambrose Cheung, Dartmouth Medical School, Hanover, NH, USA). 300 µL of thawed −80°C frozen S. aureus stocks were added to 10 ml of Tryptic Soy broth (with 2.5 µg/ml chloramphenicol selection agent for GFP+ RN6390) in 50 ml conical centrifuge tubes, and incubated at 37°C while shaking at 250 rpm for four hours. Bacteria were washed twice in cold PBS and resuspended in cold PBS, vortexed for two minutes and passed through a 5 µm syringe filter. OD 650 was used to estimate CFU from standard curves. For unopsonized experiments bacteria were suspended in cold RPMI/.3%BSA without serum or phenol red (assay buffer) at 2.67×108/ml and kept on ice until infection of cells. For IgG-opsonized experiments bacteria were diluted to 4×108/ml in assay buffer, incubated on ice for 30 minutes with 5 µg/ml mouse monoclonal IgG3 anti-S. aureus antibody (C55570M, Biodesign International, Saco, ME, USA), washed twice in cold PBS, resuspended in assay buffer at 4×107/ml, and kept on ice until infection of cells.
Preparation of heat-killed S. aureus Wood strain suspension
Live S. aureus Wood strain were prepared as described above. Following OD 650 determination bacteria (suspended in PBS) were incubated in a water bath heated to 63°C for 30 minutes, cooled on ice, centrifuged and resuspended in assay buffer at 2.67×108/ml and kept on ice until infection of cells.
Preparation of commercial killed S. aureus Wood strain suspension
Lyopholized AlexaFluor 488-conjugated heat or irradiation killed Wood strain S. aureus (Life Technologies, Carlsbad, CA, USA) was suspended in cold assay buffer at a concentration of 1.33×107/ml and sonicated for 20 seconds immediately prior to use.
Phagocytosis assay: latex beads
All reagents and buffers were at room temperature when added to cells, and all incubations were at 5% CO2 and 37°C. Adherent GM-MФs prepared as described above were incubated with 100 µM CellTracker Blue CMAC (Life Technologies) in HBSS with Ca++ and Mg++ for 40 minutes at 5% CO2 and 37°C, followed by replacement with RPMI/.3%BSA without serum or phenol red (assay buffer). Inhibitors or control solutions (table 1) were added to cells (with triplicate wells for each condition) 40 minutes prior to addition of beads. Polyinosinic acid, chondroitin sulfate, cytochalasin D, nocodazole, and staurosporine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Gö 6976, JNK Inhibitor I, JNK Inhibitor I control, and KN-93 were purchased from EMD Chemicals (San Diego, CA, USA).
For latex bead uptake assays, one micron green fluorescent carboxylated latex beads (Life Technologies) were biotinylated as previously described . Beads were suspended in assay buffer at 2.67×108/ml and sonicated for 20 seconds immediately prior to use. Cells were incubated for 20 minutes with bead suspension at a final concentration of 2×108/ml with inhibitors or controls for binding and internalization, washed three times with HBSS/0.3% BSA, and incubated an additional 20 minutes in assay buffer with inhibitors or controls for further internalization. Microplates were transferred to ice to halt internalization and cells were incubated on ice for 30 minutes with 20 µg/ml streptavidin-Texas Red (Life Technologies) in assay buffer to label external beads. Cells were then washed with HBSS/0.3% BSA and fixed with 4% paraformaldehyde in PBS for 10 minutes. Cells were stored in 1% paraformaldehyde at 4°C overnight. Cells were incubated for 60 minutes at room temperature with 2 µg/ml Hoechst 33342 (Life Technologies) in PBS for nuclear staining and then stored in PBS at 4°C until imaged.
For assays of uptake of green fluorescent S. aureus, cells were incubated for 20 minutes with unopsonized GFP+ RN6390 (final concentrations of 2×108/ml), 3×107/ml for IgG-opsonized GFP+ RN6390, or 1×107/ml for AlexaFluor 488-conjugated killed Wood strain) with inhibitors or controls (table 1) for binding and internalization, washed three times with HBSS/0.3% BSA, and incubated an additional 20 minutes in assay buffer with inhibitors or controls for further internalization. Cells were fixed with 4% paraformaldehyde in PBS for 10 minutes. To achieve red fluorescent labeling of external bacteria cells were incubated for 15 minutes with PBS/4% FBS (blocking buffer), incubated for 40 minutes with 10 µg/ml mouse monoclonal IgG3 anti-S. aureus antibody in blocking buffer, washed three times with blocking buffer, incubated for 20 minutes with 40 µg/ml Texas-RedX-conjugated goat anti-mouse IgG (Life Technologies) in blocking buffer, and washed twice with blocking buffer. Hoechst nuclear staining was then performed as described above.
In some assay validation experiments the phagocytosis assay was performed using the GFP-expressing RN6390 strain and the single inhibitor cytochalasin D (to prevent internalization) or vehicle control, with the exception that prior to fixation and immunolabeling cells were incubated for an additional 60 minutes at 5% CO2 and 37°C in assay media with cytochalasin D or control and with or without 10 µg/ml lysostaphin (Sigma-Aldrich) to dissolve external S. aureus.
For assays of uptake of non-fluorescent S. aureus strains (Seattle 1945, live Wood or Cowan 1 strain) prelabeling with CellTracker Blue, incubation of macrophages with bacteria, fixation and incubation with primary anti-S. aureus antibody was carried out as described above. For dual red and green fluorescent labeling of external bacteria, following primary antibody incubation and three washes with blocking buffer, cells were incubated for 20 minutes with both 40 µg/ml Texas-RedX conjugated goat anti-mouse IgG (Life Technologies) and 40 µg/ml AlexaFluor 488 conjugated goat anti-mouse IgG Fab fragment (Life Technologies) in blocking buffer and then washed twice with blocking buffer. For green fluorescent labeling of internal bacteria cells were permeabilized by incubation for 20 minutes with 0.1% saponin in blocking buffer (BP buffer), then incubated for 60 minutes with10 µg/ml mouse monoclonal IgG3 anti-S. aureus antibody in BP buffer, washed three times for five minutes each with BP buffer, incubated for 30 minutes with 40 µg/ml AlexaFluor 488 conjugated goat anti-mouse IgG Fab fragment in BP buffer, and washed three times for five minutes each BP buffer. Hoechst nuclear staining was then performed as described above.
Flow cytometry analysis of particle uptake in suspension
GM-MФs in suspension were prepared as described above. Polyinosinic acid or chondroitin sulfate were added to a final concentration of 10 µg/ml and cells were incubated on ice for 30 minutes. Green fluorescent latex beads, commercial killed AlexaFluor 488-conjugated S. aureus Wood strain and GFP+ S. aureus RN6390 strain suspensions, were prepared as described above (but at 2× concentrations). Volumes of 2× particle suspensions equaling cell suspension volumes were added and cells were incubated for 30 minutes at room temperature. An equal volume of 4% paraformaldehyde was added (final concentration of 2%) and cells were incubated an additional 10 minutes at room temperature for fixation. Cell suspensions were analyzed using a FacsCanto II flow cytometer (BD Biosciences).
Image acquisition and data analysis
Images were acquired using the BD Pathway 855 High-Content Bioimager and AttoVision imaging software (BD Biosciences, San Jose, CA, USA) with a 20X NA075 lens (Olympus, Center Valley, PA, USA). Green channel images of green fluorescent beads, or of GFP-expressing or AlexaFluor488-labeled S. aureus were acquired using 470/40 band-pass (BP) excitation, 515 long-pass (LP) dichroic and 515 LP emission filters, red channel images of Texas Red and Texas-RedX labeled beads or S. aureus were imaged using 560/20 BP excitation, 595 LP dichroic and 645 LP emission filters, and blue channel images of Hoechst nuclear and CellTracker Blue cytoplasmic labels were acquired using 380/20 BP excitation, 400 LP dichroic, 435 LP emission filters. Auto-focusing was performed based on Hoechst/CellTracker blue signals. For each of the three channels confocal images (with flat field correction and 2×2 binning) were collected at 1.5 µm intervals along the Z-axis throughout the thickness of the cells, and a single combined collapsed confocal stack image was generated. Three non-overlapping 20X image fields were acquired for each microplate well to produce a total of nine sets of images (3 fields ×3 wells) per condition for each cell donor.
Image analysis and quantification
Using the collapsed confocal stack images, software was developed to define the cells (blue emission channel image), count the number of beads per cell (green emission channel image) and determine if the beads are outside the cell (red emission channel image) using custom software developed in MATLAB® (The Mathworks, Inc., Natick, MA, USA). Hoechst/CellTracker Blue images were processed to reduce noise, enhance contrast and correct for non-uniform field brightness. A gradient-facilitated watershed segmentation algorithm was used to identify and label individual cells.
Green and red fluorescent bead and bacteria images were sharpened and processed to remove background noise. Watershed segmentation was used to identify and label individual bead/bacteria objects. Labeled bead or bacteria objects within the all particles (green) image channel overlapping (sharing one or more pixel with) a bead or bacteria object in the external particle (red) image channel were classified as “external”, and were otherwise classified as “internal”. Particle objects sharing one or more pixel with any cell object were considered to be associated with that cell.
Typically a total of between 500 and 1000 cells were identified and quantified (from the nine image fields acquired) per donor per condition. Binding for each donor and condition was calculated as the mean number of cell-associated beads or bacteria per cell (total particles/number of cells). The mean fraction of particles internalized by all cells for each donor and condition was calculated from the total numbers of internal and external beads or bacteria (internal/[internal + external]).
For poly(I)-treated cells mean bound particles/cell and mean fraction internalization were normalized to chondroitin sulfate control values, and significant differences were calculated using a Students paired t-test. For all other inhibitors treatment and vehicle or inactive analog control values were normalized to those of a null control, and significant differences were calculated using a one-way paired ANOVA with Tukey's multiple comparison of all means. Prism 4 for Windows (Graphpad Software, San Diego, CA, USA) was used for all graphing and statistical calculations.
Validation of scanning cytometry-based phagocytosis assay
We adapted a high-throughput phagocytosis assay, previously developed in our lab for quantification of latex bead phagocytosis , for quantification of S. aureus phagocytosis. Differential immunolabeling methods were developed for either fluorescent (GFP-expressing) or non-fluorescent S. aureus to produce an end result in which all bacteria were green-fluorescent and external bacteria were also red-fluorescent (see methods for details). To test that external labeling of bacteria was effective and limited to external bacteria, GM-MФs were incubated with GFP-S. aureus RN6390 with or without cytochalasin D treatment (to block internalization), and incubated after bacterial challenge with or without lysostaphin – an enzyme produced by Staphylococcus staphylolyticus that lyses other Staphylococcus species  by hydrolyzing glycylglycine bonds in the polyglycine cross-bridges between glycopeptide chains in the cell wall peptidoglycan of Staphylococcus species . Representative composite images of the four possible combinations are depicted in figure 1. Control cells (no treatment) show a mixture of internalized (green) and external (green+red = yellow/orange) S. aureus (figure 1A). Cytochalasin D treatment prevents internalization of bacteria making them accessible to immunolabeling; most bacteria show antibody labeling seen as yellow/orange in composite images (figure 1B). Treatment with lysostaphin alone results in cells with internalized bacteria (green) only (figure 1C). Treatment with both cytochalasin D (blocking internalization) and lysostaphin (degrading external bacteria) results in complete elimination of bacteria (figure 1D).
Adherent GM-MФs were either treated with cytochalasin D (to block uptake) or control prior to and during incubation with GFP-S. aureus RN6390 and incubated with lysostaphin (to degrade external S. aureus, eliminating external bacteria) or control following incubation with S. aureus. External S. aureus were labeled with an IgG3 monoclonal mouse anti-S. aureus primary antibody and Texas-RedX-conjugated goat anti-mouse secondary antibody. (A) No treatment. (B) Treatment with cytochalasin D. (C) Treatment with lysostaphin. (D) Treatment with both cytochalasin D and lysostaphin. (Original magnification, 200X).
Scanning cytometry was used to acquire confocal image stacks throughout the depth of the adherent cells and generate single collapsed confocal stack images for each of the three color channels (cells, all beads, internal beads) as shown in figure 2. Custom image analysis software was developed in MATLAB® and used to identify individual cell objects, count internalized vs. bound but external beads for each cell (figure 3), and calculate mean total bacteria and percent internalization for all cells in each well. To validate the automated quantification of bound and internalized bacteria we compared the results of automated image analysis to human counting of the same images. Bound and internalized bacteria per cell were manually counted for 50 cells in control and cytochalasin D treated conditions and compared to software quantification of the same 50 cells. Automated counts varied from manual counts by less than 10% for each measure (table 2).
Adherent GM-MФs were incubated with unopsonized GFP-S. aureus RN6390. External S. aureus were labeled with an IgG3 monoclonal mouse anti-S. aureus primary antibody and Texas-RedX-conjugated goat anti-mouse secondary antibody. Collapsed confocal stack images were acquired by scanning cytometry. (A) CellTracker Blue and Hoechst channel (cells). (B) GFP channel (all bacteria). (C) Texas Red channel (external bacteria). (D) Composite image. (Original magnification, 200X).
Image processing and analysis was performed using custom software developed in MATLAB®. (A) Individual cells segmented and identified in cell image. (B) Individual bacteria segmented and identified in all bacteria image. (C) Individual bacteria segmented and identified in external bacteria image. (D) Internalized (green) and bound but not internalized (red) bacteria assigned to individual cells (gray).
The SR inhibitor polyinosinic acid does not block binding of most unopsonized S. aureus
To examine the role of SRs in phagocytosis of S. aureus, adherent GM-MФs were treated with the SR blocker poly(I) or the control polyanion chondroitin sulfate prior to and during incubation with a panel of S. aureus strains. The assay also tested uptake of unopsonized latex beads, used as a positive control for SR-mediated uptake. Binding and internalization was analyzed by scanning cytometry as described in methods. At 10 µg/ml poly(I) reduced binding of latex beads by 70% compared with control (p<.001) and inhibited binding of commercial killed S. aureus Wood strain by 75% of control (p<.05). In contrast, there was no significant effect on binding of unopsonized live or heat-killed Wood, Cowan 1, Seattle 1945 (ATCC 25923) or RN6390 strains, or on that of IgG-opsonized RN6390 (figure 4A). At 100 µg/ml poly(I), minimal increases in the extent of inhibition of binding of latex beads or commercial killed Wood strain were observed, suggesting that maximal effects of this SR inhibitor were already seen at the lower concentration. At this higher concentration, a partial inhibition of binding of unopsonized RN6390 was seen (44%, p<.05). There was no significant effect at this concentration on binding of live or heat-killed Wood, Cowan 1, and Seattle 1945 (figure 4B). Representative composite images of control and poly(I) treated cells after phagocytosis of unopsonized latex beads, commercial killed Wood strain, and live Wood strain are shown in figure 5, and are consistent with the automated analysis results.
Macrophages were treated with 10 or 100 µg/ml poly(I) or its negative control chondroitin sulfate prior to and during incubation with either fluorescent latex beads or S. aureus. Bars represent the mean of the fraction of chondroitin sulfate control binding [particles per cell for adherent cells (A,B,D) and mean fluorescence increase over that of cells without particles for cells in suspension (C)] of three normal donors±SEM. (A) Results of inhibition by 10 µg/ml poly(I) of binding by adherent GM-MФs. (B) Results of inhibition by 10 vs. 100 µg/ml poly(I) of binding by adherent GM-MФs. (C) Results of inhibition by 10 µg/ml poly(I) of binding by GM-MФs in suspension. (D) Results of inhibition by 10 vs. 100 µg/ml poly(I) of binding by adherent mouse peritoneal macrophages. *p<0.05, **p<0.01, ***p<0.001 compared to negative control. CK Wood = commercial killed AlexaFluor 488-conjugated S. aureus, Wood Strain. HK Wood = heat-killed S. aureus, Wood strain.
Adherent GM-MФ were treated with 10 µg/ml poly(I) or its negative control chondroitin sulfate prior to and during incubation with either fluorescent latex beads or S. aureus (commercial killed AlexaFluor 488-conjugated Wood or live Wood strain). Images are merged composites of cell (gray), internalized beads or bacteria (green) and external beads or bacteria (red). (A,B,C) Chondroitin sulfate control. (D,E,F) Poly(I)-treated. (A,D) Cells with fluorescent latex beads. (B,E) Cells with commercial killed AlexaFluor 488-conjugated Wood strain S. aureus. (C,F) Cells with live Wood strain S. aureus.
Since some prior studies used suspension-based assays to observe SR-mediated uptake of fluorescent S. aureus, we compared results using adherent vs. suspended macrophages. GM-MФs in suspension were treated with 10 µg/ml poly(I) or chondroitin sulfate, and incubated with S. aureus (commercial killed Wood or RN6390 strain) or green fluorescent latex beads and analyzed by flow cytometry. Poly(I) reduced binding of latex beads by 90% compared with control (p<.01) and inhibited binding of commercial killed S. aureus Wood strain by 85% (p<.01), consistent with prior findings , , , , , . In contrast, there was no significant effect on binding of S. aureus RN6390 (figure 4C and figure 6).
Adherent GM-MФ in suspension were treated with 10 µg/ml poly(I) or its negative control chondroitin sulfate prior to and during incubation with either fluorescent latex beads or S. aureus (commercial killed Wood or RN6390 strain). Histograms represent green fluorescence intensity counts of 10,000 cells for a single donor. Gray histograms represent cells without particles. Green histograms represent cells with particles. (A,B,C) Chondroitin sulfate control. (D,E,F) Poly(I) treated. (A,D) Cells with fluorescent latex beads. (B,E) Cells with commercial killed AlexaFluor 488-conjugated Wood strain S. aureus. (C,F) Cells with GFP+RN6390 strain S. aureus.
We applied a similar analysis to macrophages from a different species and anatomic site, murine peritoneal exudate macrophages. Adherent mouse thioglycolate-elicited peritoneal macrophages were pre-treated with 10 or 100 µg/ml poly(I) or chondroitin sulfate and incubated with S. aureus (commercial killed or live Wood, Cowan 1 or RN6390 strain). At 10 µg/ml, poly(I) reduced binding of commercial killed Wood strain by 82% compared with control (p<.01) and had no effect on binding of other S. aureus forms (figure 4D). At 100 µg/ml poly(I), binding of commercial killed Wood strain was inhibited by 80% (p<.01), binding of RN6390 strain was partially inhibited (similar to our findings with the human macrophages, ∼45%, p<.05) and binding of live Wood and Cowan 1 strains was unaffected (figure 4D).
Effect of signaling and cytoskeletal inhibitors on phagocytosis of unopsonized S. aureus strains
To investigate the contribution of cytoskeleton and signaling pathways in phagocytosis of S. aureus, adherent GM-MФs were treated with a panel of inhibitors (table 1), or appropriate control vehicle solutions, prior to and during incubation with a panel of S. aureus strains as well as unopsonized latex beads, and analyzed by scanning cytometry as described in methods. The results are detailed in figures 7 and 8 and summarized in tables 3 and 4 show uniform effects of cytochalasin D, but extensive heterogeneity in the effects of other inhibitors among the strains tested.
Adherent GM-MФ were treated with inhibitors or controls (table 1) prior to and during incubation with either fluorescent latex beads or S. aureus. Bars represent the controls as mean percent internalization of three normal donors±SEM. (A) Effect of actin polymerization inhibitor cytochalasin D. (B) Effect of microtubule assembly inhibitor nocodazole. (C) Effect of protein kinase inhibitor staurosporine. (D) Results of protein kinase C inhibitor Gö 6976. (E) Effect of c-Jun N-kinase inhibitor JNK inhibitor I. (F) Effect of CaM kinase II inhibitor KN-93. *p<0.05, **p<0.01, ***p<0.001 compared to both no treatment control and vehicle or inactive analog control.
Adherent GM-MФs were treated with inhibitors or controls (table 1) prior to and during incubation with either fluorescent latex beads or S. aureus. Bars represent the mean of the fraction of null control particles per cell of three normal donors±SEM. (A) Results of actin polymerization inhibitor cytochalasin D. (B) Results of microtubule assembly inhibitor nocodazole. (C) Results of protein kinase inhibitor staurosporine. (D) Results of protein kinase C inhibitor Gö 6976. (E) Results of c-Jun N-kinase inhibitor JNK inhibitor I. (F) Results of CaM kinase II inhibitor KN-93. *p<0.05, **p<0.01, ***p<0.001 compared to both null control and vehicle or inactive analog control.
Inhibition of actin polymerization by cytochalasin D (15 µM) strongly inhibited internalization of all S. aureus forms and latex beads (figure 7A). Nocodazole-mediated inhibition of microtubule formation reduced internalization of latex beads by 45% (p<.001), of commercial killed S. aureus Wood strain by 16% (p<.001) and of live Wood strain by 29% (p<.001), but had no significant effect on internalization of other unopsonized S. aureus strains or that of IgG-opsonized RN6390 strain (figure 7B).
Another example of heterogeneity can be seen in the pattern of inhibition resulting from staurosporine (1 µM) inhibition of protein kinase activity. Staurosporine blocked internalization of unopsonized beads by 59% (p<.001), commercial S. aureus killed Wood strain by 18% (p<.01) and live Wood strain by 29% (p<.001), but had no significant effect on internalization of other unopsonized strains of S. aureus or IgG-opsonized RN6390 (figure 7C).
Additional illustration of varied effects is seen in, inhibition of CaM kinase II by KN-93 (4 µM) treatment reduced both internalization (40%, p<.01) and binding (89%, p<.001) of unopsonized S. aureus RN6390 strain, but had no effect on phagocytosis of latex beads, other unopsonized S. aureus strains, or IgG-opsonized RN6390 (figure 7E and figure 8E).
We have developed and demonstrated the utility of a high throughput assays for quantifying phagocytosis of fluorescent or non-fluorescent bacteria by adherent macrophages in a 96-well microplate format. Assays of unopsonized latex bead and opsonized S. aureus RN6390 phagocytosis served as positive controls. Consistent with previous reports, binding of unopsonized beads was strongly blocked by the SR antagonist polyinosinic acid, and uptake of beads was significantly reduced by inhibition of actin (cytochalasin D) and tubulin (nocodazole) polymerization, protein kinases (staurosporine), protein kinase C (Gö 6976), and c-Jun N-terminal kinases (JNK). Also consistent with earlier studies, our assay showed that the uptake of IgG-opsonized (FcγR-mediated) uptake of S. aureus RN6390 was blocked by inhibition of cytochalasin D, but not by nocodazole or staurosporine.
Surprisingly, however, the classic SR inhibitor polyinosinic acid did not block binding of live S. aureus strains or of heat-killed S. aureus Wood strain, and a marked heterogeneity of inhibition patterns was found among strains and forms of S. aureus within the panel of inhibitors investigated.
A number of earlier studies have demonstrated the role of scavenger receptors, particularly SR-AI/II and MARCO, in phagocytosis of Gram-positive bacteria via the cell surface ligand lipoteichoic acid (LTA) , –. Many of these studies, including our own efforts, have utilized a commercial preparation of killed Wood strain bacteria , , , , . Our results using this killed Wood strain in the experiments reported here are quite similar to prior findings. Binding by GM-MФs or adherent mouse peritoneal macrophages was almost completely abrogated by polyinosinic acid at 10 µg/ml. However, at the same concentration, polyinosinic acid did not block binding of live or heat-killed Wood strain, or live Seattle 1945, Cowan 1, or RN6390 strains, and only partially blocked binding of RN6390 strain at 100 µg/ml. These results suggest that SRs do not play a major role in the unopsonized phagocytosis of live or clinically relevant strains of S. aureus, and that the commercial killed Wood strain may be peculiar among S. aureus forms in its SR-mediated uptake. Although the panel of S. aureus strains studied here is far from comprehensive the consistency in this regard among those that were studied is noteworthy. The general concept of SR-mediated uptake of Gram-positive bacteria via their cell wall LTA, a known SR ligand, may require refinement. The data suggest that alternative receptors are likely involved. Indeed, a recent study of AM uptake of Streptococcus pyogenes revealed an ability of some pathogenic strains to evade SR-mediated uptake .
These findings are distinct from those of Thomas et. al. REF. They reported that SR-A deficient mice showed diminished clearance of live S. aureus Cowan 1 strain, as well as decreased survival, after i.p. injection. They also observed of impaired unopsonized phagocytosis of Cowan 1 strain in vitro by peritoneal macrophages from the same mice, and strong in vitro poly(I) inhibition of unopsonized Cowan 1 strain phagocytosis by peritoneal macrophages from wild-type mice . One possible explanation for the discordance between our results and the in vivo results reported by Thomas et. al. is that mouse peritoneal macrophages might behave differently than human alveolar-like macrophages in this regard. Another possibility is that even though macrophage SR may not play a major role in binding of unopsonized S. aureus, SR binding may be facilitated after in vivo opsonization with serum or other components that are SR ligands. These speculations cannot, however, reconcile our in vitro poly(I) results with the Cowan 1 strain with those of Thomas et al., since we were unable to detect inhibition of binding by either human GM-MФs or wild-type mouse peritoneal macrophages. Hence, the basis for these differences remains unresolved.
A second surprising finding in our study was a remarkable variation among S. aureus strains in the effect of signaling inhibitors on uptake. Whereas inhibition of actin polymerization blocked uptake of all S. aureus strains and forms and inhibited binding of RN6390 strain only, blockade of microtubule assembly by nocodazole impaired internalization of the Wood strain (live or commercial killed) only and blocked binding of all but the RN6390 strain. Protein kinase inhibition by staurosporine inhibited uptake of live or commercial killed Wood strain, and PKC inhibition by Gö 6976 inhibited uptake of commercial killed Wood strain only. JNK inhibition had no effect on uptake of any strain or form of S. aureus. Finally CaM Kinase II inhibition by KN-93 blocked both binding and internalization of unopsonized RN6390 strain, but had no effect on phagocytosis of other strains. This heterogeneity of inhibition profiles among strains suggests that multiple signaling and cytoskeletal/mechanical process schemes for unopsonized phagocytosis exist and that the scheme used by the macrophage is determined by some as yet unknown variable strain-dependent characteristic of S. aureus.
We have used the high-throughput phagocytosis assay to investigate the effects of a relatively small panel of inhibitors on phagocytosis of a similarly small number of S. aureus strains. Further larger-scale studies utilizing more comprehensive inhibitor panels, or RNAi knockdown cell libraries are possible to more completely characterize the signaling pathways utilized by these and other S. aureus strains. The high-throughput scanning-cytometry based methods developed in the present study are well suited for these purposes. These techniques could also easily be adapted to study phagocytosis of other microorganisms by other cell types, and with the additional labeling of dead vs. live bacteria could be adapted to allow study of both phagocytosis and killing of pathogens.
We would like to thank Sally Bedugnis for her technical assistance in preparation of cells, care of mice and flow cytometry, Jean Lai for support with the scanning cytometry, and Sanjukta Ghosh for helping with the mouse experiments. Initial stocks of GFP-expressing S. aureus RN6390 were generously provided by Dr. Ambrose Cheung (Dartmouth Medical School, Hanover, NH, USA).
Conceived and designed the experiments: GMD THS AI LK. Performed the experiments: GMD. Analyzed the data: GMD. Contributed reagents/materials/analysis tools: THS AI LK. Wrote the paper: GMD LK. Provided critical review and contributed to revision of the paper: THS AI LK. Approved final revision of paper: THS AI LK.
- 1. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, et al. (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128: 3854–3862.MH KollefA. ShorrYP TabakV. GuptaLZ Liu2005Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.Chest12838543862
- 2. van der Laan LJ, Dopp EA, Haworth R, Pikkarainen T, Kangas M, et al. (1999) Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 162: 939–947.LJ van der LaanEA DoppR. HaworthT. PikkarainenM. Kangas1999Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo.J Immunol162939947
- 3. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA (1994) The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A 91: 1863–1867.DW DunneD. ResnickJ. GreenbergM. KriegerKA Joiner1994The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid.Proc Natl Acad Sci U S A9118631867
- 4. Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, et al. (1999) Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med 189: 1497–1506.A. PalecandaJ. PaulauskisE. Al-MutairiA. ImrichG. Qin1999Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles.J Exp Med18914971506
- 5. Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, et al. (2000) Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med 191: 147–156.CA ThomasY. LiT. KodamaH. SuzukiSC Silverstein2000Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis.J Exp Med191147156
- 6. Peiser L, Gough PJ, Kodama T, Gordon S (2000) Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun 68: 1953–1963.L. PeiserPJ GoughT. KodamaS. Gordon2000Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro.Infect Immun6819531963
- 7. Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, et al. (2004) The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med 200: 267–272.M. ArredouaniZ. YangY. NingG. QinR. Soininen2004The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.J Exp Med200267272
- 8. Arredouani MS, Palecanda A, Koziel H, Huang YC, Imrich A, et al. (2005) MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol 175: 6058–6064.MS ArredouaniA. PalecandaH. KozielYC HuangA. Imrich2005MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages.J Immunol17560586064
- 9. Zhou H, Imrich A, Kobzik L (2008) Characterization of immortalized MARCO and SR-AI/II-deficient murine alveolar macrophage cell lines. Part Fibre Toxicol 5: 7.H. ZhouA. ImrichL. Kobzik2008Characterization of immortalized MARCO and SR-AI/II-deficient murine alveolar macrophage cell lines.Part Fibre Toxicol57
- 10. Pluddemann A, Neyen C, Gordon S (2007) Macrophage scavenger receptors and host-derived ligands. Methods 43: 207–217.A. PluddemannC. NeyenS. Gordon2007Macrophage scavenger receptors and host-derived ligands.Methods43207217
- 11. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR (1991) Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352: 342–344.RY HamptonDT GolenbockM. PenmanM. KriegerCR Raetz1991Recognition and plasma clearance of endotoxin by scavenger receptors.Nature352342344
- 12. Elshourbagy NA, Li X, Terrett J, Vanhorn S, Gross MS, et al. (2000) Molecular characterization of a human scavenger receptor, human MARCO. Eur J Biochem 267: 919–926.NA ElshourbagyX. LiJ. TerrettS. VanhornMS Gross2000Molecular characterization of a human scavenger receptor, human MARCO.Eur J Biochem267919926
- 13. Nakamura K, Funakoshi H, Miyamoto K, Tokunaga F, Nakamura T (2001) Molecular cloning and functional characterization of a human scavenger receptor with C-type lectin (SRCL), a novel member of a scavenger receptor family. Biochem Biophys Res Commun 280: 1028–1035.K. NakamuraH. FunakoshiK. MiyamotoF. TokunagaT. Nakamura2001Molecular cloning and functional characterization of a human scavenger receptor with C-type lectin (SRCL), a novel member of a scavenger receptor family.Biochem Biophys Res Commun28010281035
- 14. Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, et al. (2001) The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J Biol Chem 276: 44222–44228.K. OhtaniY. SuzukiS. EdaT. KawaiT. Kase2001The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells.J Biol Chem2764422244228
- 15. Selman L, Skjodt K, Nielsen O, Floridon C, Holmskov U, et al. (2008) Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues. Mol Immunol 45: 3278–3288.L. SelmanK. SkjodtO. NielsenC. FloridonU. Holmskov2008Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues.Mol Immunol4532783288
- 16. Moriwaki H, Kume N, Kataoka H, Murase T, Nishi E, et al. (1998) Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett 440: 29–32.H. MoriwakiN. KumeH. KataokaT. MuraseE. Nishi1998Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha.FEBS Lett4402932
- 17. Satoh H, Kiyota E, Terasaki Y, Sawamura T, Takagi K, et al. (2008) Expression and localization of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in murine and human placentas. J Histochem Cytochem 56: 773–784.H. SatohE. KiyotaY. TerasakiT. SawamuraK. Takagi2008Expression and localization of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in murine and human placentas.J Histochem Cytochem56773784
- 18. Shimaoka T, Kume N, Minami M, Hayashida K, Sawamura T, et al. (2001) LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J Immunol 166: 5108–5114.T. ShimaokaN. KumeM. MinamiK. HayashidaT. Sawamura2001LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria.J Immunol16651085114
- 19. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O (1998) Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 334 (Pt1): 9–13.H. YoshidaN. KondratenkoS. GreenD. SteinbergO. Quehenberger1998Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor.Biochem J334 (Pt1)913
- 20. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, et al. (2000) Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 275: 40663–40666.T. ShimaokaN. KumeM. MinamiK. HayashidaH. Kataoka2000Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages.J Biol Chem2754066340666
- 21. Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, et al. (2003) Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol 171: 1647–1651.T. ShimaokaT. NakayamaN. KumeS. TakahashiJ. Yamaguchi2003Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain.J Immunol17116471651
- 22. Allen LA, Aderem A (1996) Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med 184: 627–637.LA AllenA. Aderem1996Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages.J Exp Med184627637
- 23. Araki N, Johnson MT, Swanson JA (1996) A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 135: 1249–1260.N. ArakiMT JohnsonJA Swanson1996A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages.J Cell Biol13512491260
- 24. Botelho RJ, Teruel M, Dierckman R, Anderson R, Wells A, et al. (2000) Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol 151: 1353–1368.RJ BotelhoM. TeruelR. DierckmanR. AndersonA. Wells2000Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis.J Cell Biol15113531368
- 25. Caron E, Hall A (1998) Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282: 1717–1721.E. CaronA. Hall1998Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases.Science28217171721
- 26. Cohen G, Makranz C, Spira M, Kodama T, Reichert F, et al. (2006) Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both. Glia 53: 538–550.G. CohenC. MakranzM. SpiraT. KodamaF. Reichert2006Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both.Glia53538550
- 27. Greenberg S, Chang P, Silverstein SC (1993) Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J Exp Med 177: 529–534.S. GreenbergP. ChangSC Silverstein1993Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages.J Exp Med177529534
- 28. Greenberg S, Chang P, Silverstein SC (1994) Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J Biol Chem 269: 3897–3902.S. GreenbergP. ChangSC Silverstein1994Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages.J Biol Chem26938973902
- 29. Hall AB, Gakidis MA, Glogauer M, Wilsbacher JL, Gao S, et al. (2006) Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis. Immunity 24: 305–316.AB HallMA GakidisM. GlogauerJL WilsbacherS. Gao2006Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis.Immunity24305316
- 30. Larsen EC, Ueyama T, Brannock PM, Shirai Y, Saito N, et al. (2002) A role for PKC-epsilon in Fc gammaR-mediated phagocytosis by RAW 264.7 cells. J Cell Biol 159: 939–944.EC LarsenT. UeyamaPM BrannockY. ShiraiN. Saito2002A role for PKC-epsilon in Fc gammaR-mediated phagocytosis by RAW 264.7 cells.J Cell Biol159939944
- 31. May RC, Caron E, Hall A, Machesky LM (2000) Involvement of the Arp2/3 complex in phagocytosis mediated by FcgammaR or CR3. Nat Cell Biol 2: 246–248.RC MayE. CaronA. HallLM Machesky2000Involvement of the Arp2/3 complex in phagocytosis mediated by FcgammaR or CR3.Nat Cell Biol2246248
- 32. Newman SL, Mikus LK, Tucci MA (1991) Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis. J Immunol 146: 967–974.SL NewmanLK MikusMA Tucci1991Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis.J Immunol146967974
- 33. Ninomiya N, Hazeki K, Fukui Y, Seya T, Okada T, et al. (1994) Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor signaling. J Biol Chem 269: 22732–22737.N. NinomiyaK. HazekiY. FukuiT. SeyaT. Okada1994Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor signaling.J Biol Chem2692273222737
- 34. Olazabal IM, Caron E, May RC, Schilling K, Knecht DA, et al. (2002) Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis. Curr Biol 12: 1413–1418.IM OlazabalE. CaronRC MayK. SchillingDA Knecht2002Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis.Curr Biol1214131418
- 35. Sulahian TH, Imrich A, Deloid G, Winkler AR, Kobzik L (2008) Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res 9: 59.TH SulahianA. ImrichG. DeloidAR WinklerL. Kobzik2008Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry.Respir Res959
- 36. Schindler CA, Schuhardt VT (1964) Lysostaphin: A New Bacteriolytic Agent for the Staphylococcus. Proc Natl Acad Sci U S A 51: 414–421.CA SchindlerVT Schuhardt1964Lysostaphin: A New Bacteriolytic Agent for the Staphylococcus.Proc Natl Acad Sci U S A51414421
- 37. Browder HP, Zygmunt WA, Young JR, Tavormina PA (1965) Lysostaphin: Enzymatic Mode of Action. Biochem Biophys Res Commun 19: 383–389.HP BrowderWA ZygmuntJR YoungPA Tavormina1965Lysostaphin: Enzymatic Mode of Action.Biochem Biophys Res Commun19383389
- 38. Areschoug T, Waldemarsson J, Gordon S (2008) Evasion of macrophage scavenger receptor A-mediated recognition by pathogenic streptococci. Eur J Immunol. T. AreschougJ. WaldemarssonS. Gordon2008Evasion of macrophage scavenger receptor A-mediated recognition by pathogenic streptococci.Eur J Immunol